Charles River Laboratories International, Inc. (CRL)

298.22 -8.02 (-2.62%) USD  |  NYSE  |  Oct 16, 15:40
More

Charles River Laboratories International SG&A Expense (TTM) : 762.04M for June 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 762.04M
March 31, 2026 724.70M
December 31, 2025 743.07M
September 30, 2025 742.64M
June 30, 2025 764.27M
March 31, 2025 742.51M
December 31, 2024 751.00M
September 30, 2024 752.44M
June 30, 2024 729.33M
March 31, 2024 759.30M
December 31, 2023 747.86M
September 30, 2023 750.35M
June 30, 2023 757.96M
March 31, 2023 689.91M
December 31, 2022 665.10M
September 30, 2022 609.57M
June 30, 2022 574.43M
March 31, 2022 614.22M
December 31, 2021 619.92M
September 30, 2021 618.84M
June 30, 2021 598.56M
March 31, 2021 554.77M
December 31, 2020 528.94M
September 30, 2020 515.50M
June 30, 2020 516.72M
Date Value
March 31, 2020 524.95M
December 31, 2019 517.62M
September 30, 2019 494.94M
June 30, 2019 478.47M
March 31, 2019 463.06M
December 31, 2018 443.85M
September 30, 2018 431.04M
June 30, 2018 410.44M
March 31, 2018 383.73M
December 31, 2017 371.85M
September 30, 2017 376.22M
June 30, 2017 369.44M
March 31, 2017 376.09M
December 31, 2016 367.55M
September 30, 2016 350.53M
June 30, 2016 341.10M
March 31, 2016 311.96M
December 31, 2015 300.41M
September 30, 2015 290.99M
June 30, 2015 279.24M
March 31, 2015 275.66M
December 31, 2014 269.03M
September 30, 2014 255.67M
June 30, 2014 246.10M
March 31, 2014 233.26M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
IQVIA Holdings, Inc. 2.058B
Fortrea Holdings, Inc. 412.40M
Medpace Holdings, Inc. 189.02M
Champions Oncology, Inc. 21.81M
Avantor, Inc. 1.599B